Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

Livongo Health Inc

Triple-digit revenue growth apparently wasn't enough to send shares higher when the two companies reported earnings on Wednesday.

Why Teladoc and Livongo Health Stocks Fell on Thursday

However, the hot telemedicine services provider is still loss-making.

Teladoc Crushes Q3 Estimates

Teladoc Health, Inc. (TDOC) CEO Jason Gorevic on Q3 2020 Results - Earnings Call Transcript

Shares of Teladoc Health Inc. fell more than 8% in the extended session Wednesday after the telemedicine company narrowed its quarterly loss and reported sales above expectations but called for steeper losses in the next quarter. Teladoc said it lost $26 million, or 43 cents a share, in the third quarter, compared with a loss of $20 million, or 28 cents a share, in the year-ago quarter.

Teladoc tops Q3 views, but calls for steeper loss in the next quarter

Year-over-year Q3 revenue grows 109% to $288.8 million and total visits increase 206% to 2.8 million

Teladoc Health Reports Third-Quarter 2020 Results

In this article you are going to find out whether hedge funds think Teladoc Health, Inc (NYSE:TDOC) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after adjusting for known risk attributes. It's not surprising given that hedge funds have access to better information and more resources to predict the winners in the stock market.

Were Hedge Funds Right About Embracing Teladoc Health, Inc (TDOC)?

A surge in demand for virtual health care services is likely to have contributed to Teladoc's (TDOC) earnings in Q3

Will Covid-Led Higher Demand Aid Teladoc's (TDOC) Q3 Earnings?

American Well Corporation

Both telehealth companies have seen growth accelerate during the pandemic, but your business philosophy may determine which stock is best for you.

Better Buy: Amwell vs. Teladoc

This game-changer has the potential to redefine how patients receive care in the United States.

The 1 Stock I'm Most Excited About Right Now

CrowdStrike

Intuitive Surgical

NextEra Energy

Innovative companies can deliver big-time returns to patient investors.

4 Unstoppable Stocks to Own in the New Bull Market

Investors were frightened by the $18.5 billion price tag for Livongo, but they might be missing the most important metric for valuing the company.

1 Green Flag for Teladoc's Future

Teladoc Health (TDOC) rolls out a new telemedicine solution to address mental health issues of Canadian employees.

Teladoc's (TDOC) Telemedicine Service to Improve Mental Health

Teladoc Health also receives coveted NLA endorsed partner distinction Teladoc Health also receives coveted NLA endorsed partner distinction

National Labor Alliance Expands Exclusive Relationship with Teladoc Health, Providing Broader Array of Clinical Services

Abbott Labs

The COVID-19 pandemic will likely get worse before it gets better. These two stocks could be safe havens for investors.

2 Stocks to Buy as the Third Coronavirus Wave Hits

Coronavirus relief packages eliminated restrictions on telemedicine. Growth for the company could hit a roadblock if these barriers are brought back.

1 Red Flag for Teladoc's Future

New service expands suite of Teladoc Health offerings available to Canadian employers New service expands suite of Teladoc Health offerings available to Canadian employers

Teladoc Health Launches Mental Health Telemedicine Service

Wider cross-segment of population is addressing mental health through virtual care

Teladoc Health Data Shows Broadening Mental Health Care Demand

DexCom

These two healthcare companies have much more room to grow than the tech giant does.

2 Unstoppable Stocks That Are Better Buys Than Apple

Block

Tesla

Fastly

Financial Twitter is abuzz about these high-growth companies.

5 of the Most Talked-About FinTwit Stocks

PayPal

Each of them benefits from unstoppable trends.

3 Stocks Poised to Be Surefire Winners in the New Bull Market

Novavax

These companies have benefited significantly from the COVID-19 pandemic already, and it looks like they have much more room to grow.

3 Pandemic Stocks That Could Make You Rich

Here's how it could shift the future of the entire healthcare industry.

Teladoc Health & Livongo Merger-Explained

Innovative Industrial Properties

Visa

You don't need deep pockets to build wealth on Wall Street.

3 of the Best Stocks You Can Buy With $250

Teladoc (TDOC) closed at $230.45 in the latest trading session, marking a -0.58% move from the prior day.

Teladoc (TDOC) Stock Moves -0.58%: What You Should Know

It accuses its rival of nine violations related to two products.

News for Teladoc Stock (TDOC)